Patents matching “treatment”

US 12274723

Bacteriophage compositions and methods for treatment of bacterial infections

United States Government as represented by the Department of Veterans Affairs · Granted Apr 15, 2025 · Expires Apr 10, 2045

US 12270814

Kits and methods for prediction and treatment of preeclampsia

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 8, 2025 · Expires Apr 3, 2045

US 12268720

Bacteriophage for treatment and prevention of E. coli and B. fragilis infections

Armata Pharmaceuticals, Inc. · Granted Apr 8, 2025 · Expires Apr 3, 2045

US 12263139

Use of cannabidiol in the treatment of tuberous sclerosis complex

JAZZ PHARMACEUTICALS RESEARCH UK LIMITED · Granted Apr 1, 2025 · Expires Mar 27, 2045

US 12263180

Method for treatment of COVID-19-associated conditions

Rigel Pharmaceuticals, Inc. · Granted Apr 1, 2025 · Expires Mar 27, 2045

US 12257266

Stem cell-derived exosomes for the treatment of corneal scarring

The Regents of the University of California · Granted Mar 25, 2025 · Expires Mar 20, 2045

US 12247978

Compositions and methods for detection and treatment of coronavirus infection

Arizona Board of Regents on Behalf of Northern Arizona University · Granted Mar 11, 2025 · Expires Mar 6, 2045

US 12247201

Materials and methods for treatment of autosomal dominant retinitis pigmentosa

CRISPR THERAPEUTICS AG · Granted Mar 11, 2025 · Expires Mar 6, 2045

US 12247213

Treatment of mucopolysaccharidosis IVA

REGENXBIO INC. · Granted Mar 11, 2025 · Expires Mar 6, 2045

US 12247973

Plasma membrane citrate transporter for use in the diagnosis and treatment of cancer

UNIVERSITÄTSKLINIKUM REGENSBURG · Granted Mar 11, 2025 · Expires Mar 6, 2045

US 12247037

1-(2,6-diazaspiro[3.3]heptan-6-yl)-5,6-dihydro-4h-benzo[f][1,2,4]triazolo[4,3-A][1,4]diazepine derivatives and related compounds as vasopressin antagonists for the treatment of neuro-psychological disorders

Neumora Therapeutics, Inc. · Granted Mar 11, 2025 · Expires Mar 6, 2045

US 12239712

Combination therapy for the treatment of liver disease

GALMED RESEARCH AND DEVELOPMENT LTD · Granted Mar 4, 2025 · Expires Feb 27, 2045

US 12239729

TRPV3 agonists for the treatment of skin conditions

Soricimed Biopharma Inc. · Granted Mar 4, 2025 · Expires Feb 27, 2045

US 2025064788

TREATMENT OF MIGRAINE

ALLERGAN PHARMACEUTICALS INT LTD [IE] · Granted Feb 27, 2025 · Expires Feb 22, 2045

US 12233042

Treatment of cutaneous disorders

Verrica Pharmaceuticals Inc. · Granted Feb 25, 2025 · Expires Feb 20, 2045

US 12233073

Skin care formulations and skin cancer treatment

Regents of the University of Minnesota · Granted Feb 25, 2025 · Expires Feb 20, 2045

US 12233129

Methods and compositions for the treatment of cancer

SOUTH DAKOTA BOARD OF REGENTS · Granted Feb 25, 2025 · Expires Feb 20, 2045

US 12226610

Treatment of pain associated with total knee arthroplasty with sustained-release liposomal anesthetic compositions

Pacira Pharmaceuticals, Inc. · Granted Feb 18, 2025 · Expires Feb 13, 2045

US 12226456

Nasal powder formulation for treatment of hypoglycemia

Amphastar Pharmaceuticals, Inc. · Granted Feb 18, 2025 · Expires Feb 13, 2045

US 12227479

Dihydropyridines for the treatment of cognitive impairment or traumatic brain injury

United States Government as represented by the Department of Veterans Affairs · Granted Feb 18, 2025 · Expires Feb 13, 2045

US 12226417

Fatty liver disease treatment using glucocorticoid and mineralocorticoid receptor antagonists

Corcept Therapeutics Incorporated · Granted Feb 18, 2025 · Expires Feb 13, 2045

US 12228582

Method and apparatus for testing near infrared-photoimmunotherapy treatment

The United States of America as Represented By The Secretary of the Department of Health and Human · Granted Feb 18, 2025 · Expires Feb 13, 2045

US 12227482

Compounds and compositions for the treatment of cancer

The Regents of the University of California · Granted Feb 18, 2025 · Expires Feb 13, 2045

US 12226373

Treatment of fragile X syndrome with cannabidiol

Harmony Biosciences Management, Inc. · Granted Feb 18, 2025 · Expires Feb 13, 2045